Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 45
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Qual Life Res ; 33(1): 123-132, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-37615735

RESUMEN

PURPOSE: Patients with COVID-19 present long-term symptoms collectively known as "post-COVID syndrome". Long-term manifestations are more frequent in patients requiring admission to Intensive Care Units (ICU), but the risk factors for their development are still unknown. This study explores the quality of life of patients with severe COVID-19 one year after their discharge from ICU. METHODS: Prospective observational study including 106 patients admitted to the ICU of a tertiary care hospital between March and August 2020. We analysed quality of life using the EuroQol-5D index (EQ-5D). We evaluated as possible risk factors associated with a worse value of the EQ-5D index the medical record, the clinical situation at hospital admission, the clinical situation at ICU admission and evolution in the ICU. As a secondary objective, we explored the presence of other frequent symptoms. RESULTS: Most patients (55.4%) reported that their quality of life worsened one year after admission. The mean perceived health status, on the EQ-VAS scale (0-100), was 70.4, with a median of 70 (RI 60-90). The median EQ-5D index was 0.91 (RI 0.76-1). The factors independently related to lower quality of life were female sex and duration of mechanical ventilation. Almost all (91%) of the patients had sequelae one year after discharge from the ICU. The most frequent manifestations were neuropsychiatric (71%). CONCLUSIONS: Critically ill COVID-19 patients worsen their quality of life more than one year after discharge. Female sex and duration of mechanical ventilation predict a lower quality of life assessed by the EQ-5D index.


Asunto(s)
COVID-19 , Calidad de Vida , Humanos , Femenino , Masculino , Calidad de Vida/psicología , ARN Viral , Pronóstico , COVID-19/epidemiología , SARS-CoV-2 , Unidades de Cuidados Intensivos
2.
Br J Anaesth ; 121(6): 1212-1214, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30442246

RESUMEN

Blood troponins are used to diagnose perioperative myocardial injury and infarction. During liver transplantation, a passive donor-recipient troponin transfer with the graft may result in an increase of troponins in the transplant recipient questioning the diagnosis of myocardial injury. We present a case of liver transplantation with sudden elevation of recipient's serum troponin levels immediately after graft reperfusion and its subsequent normalization in which myocardial damage and other non-ischaemic potential causes were ruled out. Patient consent for publication was obtained prior to submission of the manuscript.


Asunto(s)
Trasplante de Hígado/métodos , Troponina/administración & dosificación , Adulto , Electrocardiografía , Humanos , Masculino , Persona de Mediana Edad , Donantes de Tejidos , Troponina T/sangre
3.
Br J Anaesth ; 119(4): 655-663, 2017 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-29121283

RESUMEN

BACKGROUND: Recent studies report the immunomodulatory lung-protective role of halogenated anaesthetics during lung resection surgery (LRS) but have not investigated differences in clinical postoperative pulmonary complications (PPCs). The main goal of the present study was to compare the effect of sevoflurane and propofol on the incidence of PPCs in patients undergoing LRS. The second aim was to compare pulmonary and systemic inflammatory responses to LRS. METHODS: Of 180 patients undergoing LRS recruited, data from 174 patients were analysed. Patients were randomized to two groups (propofol or sevoflurane) and were managed otherwise using the same anaesthetic protocol. Bronchoalveolar lavage (BAL) was performed in both lungs before and after one-lung ventilation for analysis of cytokines. Arterial blood was drawn for measurement of the cytokines analysed in the BAL fluid at five time points. Intraoperative haemodynamic and respiratory parameters, PPCs (defined following the ARISCAT study), and mortality during the first month and yr were recorded. RESULTS: More PPCs were detected in the propofol group (28.4% vs 14%, OR 2.44 [95% CI, 1.14-5.26]). First-yr mortality was significantly higher in the propofol group (12.5% vs 2.3%, OR 5.37 [95% CI, 1.23-23.54]). Expression of lung and systemic pro-inflammatory cytokines was greater in the propofol group than in the sevoflurane group. Pulmonary and systemic IL-10 release was less in the propofol group. CONCLUSIONS: Our results suggest that administration of sevoflurane during LRS reduces the frequency of the PPCs recorded in our study and attenuates the pulmonary and systemic inflammatory response. CLINICAL TRIAL REGISTRATION: NCT 02168751; EudraCT 2011-002294-29.


Asunto(s)
Anestésicos por Inhalación/farmacología , Anestésicos Intravenosos/farmacología , Enfermedades Pulmonares/epidemiología , Pulmón/cirugía , Ventilación Unipulmonar/efectos adversos , Complicaciones Posoperatorias/epidemiología , Síndrome de Respuesta Inflamatoria Sistémica/epidemiología , Adulto , Anciano , Anciano de 80 o más Años , Líquido del Lavado Bronquioalveolar , Comorbilidad , Citocinas/metabolismo , Femenino , Humanos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/metabolismo , Propofol/farmacología , Sevoflurano/farmacología , Síndrome de Respuesta Inflamatoria Sistémica/metabolismo , Tiempo , Adulto Joven
4.
Br J Anaesth ; 112(5): 929-35, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24496783

RESUMEN

BACKGROUND: Postoperative continuous positive airway pressure (CPAP) can improve lung function. The aim of our study was to assess the efficacy of prophylactic CPAP on the Pa(O2)/FI(O2) ratio measured the day after surgery in patients undergoing lung resection surgery (LRS). METHODS: The study population comprised 110 patients undergoing LRS. On arrival in the postanaesthesia care unit (PACU), patients were randomized to receive CPAP at 5-7 cm H2O during the first 6 h after surgery (CPAP group) or supplemental oxygen through a Venturi mask (Venturi group). The Pa(O2)/FI(O2) ratio was measured on arrival in the PACU, 7 h after admission, and the day after surgery. The Pa(O2)/FI(O2) ratio is the primary endpoint of our study. We also analysed the chest radiograph and assessed the postoperative course. We then analysed the impact of ventilatory management in the PACU depending on the respiratory risk of the patient. RESULTS: Baseline characteristics were similar in both groups. Patients who received CPAP had significantly higher Pa(O2)/FI(O2) at 24 h after surgery compared with patients managed conventionally (Venturi group) (48.6±14 vs 42.3±12, P=0.031), but there were no differences at 7 h. On subgroup analysis, we found that the benefits of CPAP were greater in higher risk patients. The incidence of postoperative pulmonary complications and stay in the PACU and hospital were similar in both groups. CONCLUSIONS: In patients undergoing LRS, prophylactic CPAP during the first 6 h after surgery with a pressure of 5-7 cm H2O improved the Pa(O2)/FI(O2) ratio at 24 h. This effect was more evident in patients with increased risk of postoperative pulmonary complications.


Asunto(s)
Presión de las Vías Aéreas Positiva Contínua/métodos , Pulmón/fisiopatología , Pulmón/cirugía , Máscaras , Oxígeno/administración & dosificación , Cuidados Posoperatorios/métodos , Intercambio Gaseoso Pulmonar/fisiología , Adulto , Anciano , Anciano de 80 o más Años , Diseño de Equipo , Femenino , Humanos , Masculino , Persona de Mediana Edad , Resultado del Tratamiento , Adulto Joven
5.
Artículo en Inglés | MEDLINE | ID: mdl-38636796

RESUMEN

BACKGROUND: Postoperative pulmonary complications (PPC) are the most frequent postoperative complications, with an estimated prevalence in elective surgery ranging from 20% in observational cohort studies to 40% in randomized clinical trials. However, the prevalence of PPCs in patients undergoing emergency abdominal surgery is not well defined. Lung-protective ventilation aims to minimize ventilator-induced lung injury and reduce PPCs. The open lung approach (OLA), which combines recruitment manoeuvres (RM) and positive end-expiratory pressure (PEEP) titration, aims to minimize areas of atelectasis and the development of PPCs; however, there is no conclusive evidence in the literature that OLA can prevent PPCs. The purpose of this study is to compare an individualized perioperative OLA with conventional standardized lung-protective ventilation in patients undergoing emergency abdominal surgery with clinical signs of intraoperative lung collapse. METHODS: Randomized international clinical trial to compare an individualized perioperative OLA (RM plus individualized PEEP and individualized postoperative respiratory support) with conventional lung-protective ventilation (standard PEEP of 5 cmH2O and conventional postoperative oxygen therapy) in patients undergoing emergency abdominal surgery with clinical signs of lung collapse. Patients will be randomised to open-label parallel groups. The primary outcome is any severe PPC during the first 7 postoperative days, including: acute respiratory failure, pneumothorax, weaning failure, acute respiratory distress syndrome, and pulmonary infection. The estimated sample size is 732 patients (366 per group). The final sample size will be readjusted during the interim analysis. DISCUSSION: The Individualized Perioperative Open-lung Ventilatory Strategy in emergency abdominal laparotomy (iPROVE-EAL) is the first multicentre, randomized, controlled trial to investigate whether an individualized perioperative approach prevents PPCs in patients undergoing emergency surgery.


Asunto(s)
Abdomen , Laparotomía , Respiración con Presión Positiva , Complicaciones Posoperatorias , Humanos , Abdomen/cirugía , Urgencias Médicas , Atención Perioperativa/métodos , Respiración con Presión Positiva/métodos , Complicaciones Posoperatorias/prevención & control , Complicaciones Posoperatorias/epidemiología , Estudios Prospectivos , Ensayos Clínicos Controlados Aleatorios como Asunto , Respiración Artificial/métodos
6.
Rev Esp Anestesiol Reanim (Engl Ed) ; 70(10): 561-568, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-37717632

RESUMEN

INTRODUCTION: Patients with SARS-CoV-2 infection may present cardiovascular involvement including myocarditis, arrhythmias and QT interval prolongation. Our objective was to evaluate the impact of COVID-19 and its treatment on ventricular repolarization and development of arrhythmias in critically ill patients. METHODS: Retrospective cohort study of critically ill COVID-19 patients during a 3-month period in whom at least one ECG was available. Relevant clinical data and specific treatment administered for COVID-19 were recorded. Prolonged QTc was considered prolonged when it measured ≥ 460 ms in women and ≥450 ms in men. The incidence and type of arrhythmias during the same period were recorded. RESULTS: A total of 77 patients with a mean age of 62 ±â€¯13 years, 20 women and 57 men, were evaluated. Sixty percent of the patients were hypertensive, 52% had a BMI > 30, and 70% developed acute renal failure during admission. Some 56% of the patients presented QTc prolongation. Forty-four percent presented some type of arrhythmia during their stay in the ICU, 21% of which were atrial arrhythmias. Overall mortality was 53%, with no differences between patients with or without prolonged QTc. CONCLUSIONS: In our series, a high proportion of critical patients with COVID-19 presented prolonged QTc and arrhythmias. The factors involved have been related to the elevation of cardiac biomarkers, the myocardial involvement of the virus and concomitant medication received in the ICU.


Asunto(s)
COVID-19 , Síndrome de QT Prolongado , Masculino , Humanos , Femenino , Persona de Mediana Edad , Anciano , COVID-19/complicaciones , COVID-19/epidemiología , Estudios de Cohortes , Estudios Retrospectivos , Enfermedad Crítica , Pandemias , Prevalencia , SARS-CoV-2 , Síndrome de QT Prolongado/epidemiología , Síndrome de QT Prolongado/complicaciones , Arritmias Cardíacas/epidemiología , Arritmias Cardíacas/etiología
7.
Rev Esp Anestesiol Reanim (Engl Ed) ; 69(5): 266-301, 2022 05.
Artículo en Inglés | MEDLINE | ID: mdl-35610172

RESUMEN

The introduction of video-assisted thoracoscopic (VATS) techniques has led to a new approach in thoracic surgery. VATS is performed by inserting a thoracoscope through a small incisions in the chest wall, thus maximizing the preservation of muscle and tissue. Because of its low rate of morbidity and mortality, VATS is currently the technique of choice in most thoracic procedures. Lung resection by VATS reduces prolonged air leaks, arrhythmia, pneumonia, postoperative pain and inflammatory markers. This reduction in postoperative complications shortens hospital length of stay, and is particularly beneficial in high-risk patients with low tolerance to thoracotomy. Compared with conventional thoracotomy, the oncological results of VATS surgery are similar or even superior to those of open surgery. This aim of this multidisciplinary position statement produced by the thoracic surgery working group of the Spanish Society of Anesthesiology and Reanimation (SEDAR), the Spanish Society of Thoracic Surgery (SECT), and the Spanish Association of Physiotherapy (AEF) is to standardize and disseminate a series of perioperative anaesthesia management guidelines for patients undergoing VATS lung resection surgery. Each recommendation is based on an in-depth review of the available literature by the authors. In this document, the care of patients undergoing VATS surgery is organized in sections, starting with the surgical approach, and followed by the three pillars of anaesthesia management: preoperative, intraoperative, and postoperative anaesthesia.


Asunto(s)
Anestesia , Anestesiología , Cirugía Torácica , Humanos , Pulmón , Modalidades de Fisioterapia , Neumonectomía/efectos adversos , Cirugía Torácica Asistida por Video/efectos adversos , Cirugía Torácica Asistida por Video/métodos
8.
Rev Esp Anestesiol Reanim (Engl Ed) ; 69(4): 208-241, 2022 04.
Artículo en Inglés | MEDLINE | ID: mdl-35585017

RESUMEN

In recent years, multidisciplinary programs have been implemented that include different actions during the pre, intra and postoperative period, aimed at reducing perioperative stress and therefore improving the results of patients undergoing surgical interventions. Initially, these programs were developed for colorectal surgery and from there they have been extended to other surgeries. Thoracic surgery, considered highly complex, like other surgeries with a high postoperative morbidity and mortality rate, may be one of the specialties that most benefit from the implementation of these programs. This review presents the recommendations made by different specialties involved in the perioperative care of patients who require resection of a lung tumor. Meta-analyzes, systematic reviews, randomized and non-randomized controlled studies, and retrospective studies conducted in patients undergoing this type of intervention have been taken into account in preparing the recommendations presented in this guide. The GRADE scale has been used to classify the recommendations, assessing on the one hand the level of evidence published on each specific aspect and, on the other hand, the strength of the recommendation with which the authors propose its application. The recommendations considered most important for this type of surgery are those that refer to pre-habilitation, minimization of surgical aggression, excellence in the management of perioperative pain and postoperative care aimed at providing rapid postoperative rehabilitation.


Asunto(s)
Anestesia , Cirugía Torácica , Humanos , Pulmón , Dolor , Estudios Retrospectivos , Procedimientos Quirúrgicos Vasculares
9.
Artículo en Inglés, Español | MEDLINE | ID: mdl-34294445

RESUMEN

In recent years, multidisciplinary programs have been implemented that include different actions during the pre, intra and postoperative period, aimed at reducing perioperative stress and therefore improving the results of patients undergoing surgical interventions. Initially, these programs were developed for colorectal surgery and from there they have been extended to other surgeries. Thoracic surgery, considered highly complex, like other surgeries with a high postoperative morbidity and mortality rate, may be one of the specialties that most benefit from the implementation of these programs. This review presents the recommendations made by different specialties involved in the perioperative care of patients who require resection of a lung tumor. Meta-analyses, systematic reviews, randomized and non-randomized controlled studies, and retrospective studies conducted in patients undergoing this type of intervention have been taken into account in preparing the recommendations presented in this guide. The GRADE scale has been used to classify the recommendations, assessing on the one hand the level of evidence published on each specific aspect and, on the other hand, the strength of the recommendation with which the authors propose its application. The recommendations considered most important for this type of surgery are those that refer to pre-habilitation, minimization of surgical aggression, excellence in the management of perioperative pain and postoperative care aimed at providing rapid postoperative rehabilitation.

10.
Artículo en Inglés, Español | MEDLINE | ID: mdl-34330548

RESUMEN

The introduction of video-assisted thoracoscopic (VATS) techniques has led to a new approach in thoracic surgery. VATS is performed by inserting a thoracoscope through a small incisions in the chest wall, thus maximizing the preservation of muscle and tissue. Because of its low rate of morbidity and mortality, VATS is currently the technique of choice in most thoracic procedures. Lung resection by VATS reduces prolonged air leaks, arrhythmia, pneumonia, postoperative pain and inflammatory markers. This reduction in postoperative complications shortens hospital length of stay, and is particularly beneficial in high-risk patients with low tolerance to thoracotomy. Compared with conventional thoracotomy, the oncological results of VATS surgery are similar or even superior to those of open surgery. This aim of this multidisciplinary position statement produced by the thoracic surgery working group of the Spanish Society of Anesthesiology and Reanimation (SEDAR), the Spanish Society of Thoracic Surgery (SECT), and the Spanish Association of Physiotherapy (AEF) is to standardize and disseminate a series of perioperative anaesthesia management guidelines for patients undergoing VATS lung resection surgery. Each recommendation is based on an in-depth review of the available literature by the authors. In this document, the care of patients undergoing VATS surgery is organized in sections, starting with the surgical approach, and followed by the three pillars of anaesthesia management: preoperative, intraoperative, and postoperative anaesthesia.

14.
Rev Esp Anestesiol Reanim ; 53(9): 571-4, 2006 Nov.
Artículo en Español | MEDLINE | ID: mdl-17297834

RESUMEN

Thymectomy continues to be the treatment of choice for certain patients with myasthenia gravis. As surgical techniques have developed, anesthesiologists have considered the need to adapt anesthetic techniques to improve care of patients undergoing this procedure. We describe the anesthetic management of 2 patients undergoing thymectomy performed with a bilateral thoracoscopic approach. Because it is best to avoid the use of opiates during and after surgery, we performed a bilateral paravertebral thoracic block, inserting the catheters into the paravertebral space on each side to infuse local anesthetics on either side as needed as the operation progressed. Surgery was completed without adverse events and tubes were removed from the tracheas of both patients at the end of the procedures. Bilateral continuous infusion of local anesthetics provided satisfactory analgesia on the following days.


Asunto(s)
Anestésicos Locales/administración & dosificación , Miastenia Gravis/cirugía , Bloqueo Nervioso , Cirugía Torácica Asistida por Video , Timectomía , Timoma/cirugía , Neoplasias del Timo/cirugía , Adulto , Analgesia/métodos , Androstanoles/administración & dosificación , Androstanoles/farmacocinética , Anestesia por Inhalación , Terapia Combinada , Contraindicaciones , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Éteres Metílicos , Miastenia Gravis/tratamiento farmacológico , Miastenia Gravis/etiología , Fármacos Neuromusculares no Despolarizantes/administración & dosificación , Fármacos Neuromusculares no Despolarizantes/farmacocinética , Dolor Postoperatorio/prevención & control , Bromuro de Piridostigmina/uso terapéutico , Rocuronio , Sevoflurano , Timoma/complicaciones , Neoplasias del Timo/complicaciones
17.
Rev Esp Anestesiol Reanim ; 52(10): 617-26; quiz 626, 630, 2005 Dec.
Artículo en Español | MEDLINE | ID: mdl-16435617

RESUMEN

A variety of strategies have been used to reduce the high prevalence and mortality rates of cardiac complications in patients undergoing noncardiac surgery. One approach taken is to prescribe agents that block beta-adrenergic receptors. The effect of beta-blockers on myocardial ischemia is multifactorial: they correct myocardial oxygen imbalance, prevent rupture of atheromatous plaque, and reduce coronary vasoconstriction. We summarize the results of several recently published studies that confirm the beneficial effects and the low incidence of side effects.


Asunto(s)
Antagonistas Adrenérgicos beta/uso terapéutico , Cardiopatías/prevención & control , Complicaciones Intraoperatorias/prevención & control , Complicaciones Posoperatorias/prevención & control , Medicación Preanestésica , Procedimientos Quirúrgicos Operativos , Antagonistas Adrenérgicos beta/administración & dosificación , Antagonistas Adrenérgicos beta/efectos adversos , Antagonistas Adrenérgicos beta/farmacología , Anciano , Arritmias Cardíacas/tratamiento farmacológico , Arritmias Cardíacas/prevención & control , Aterosclerosis/tratamiento farmacológico , Ensayos Clínicos como Asunto , Contraindicaciones , Medicina Basada en la Evidencia , Hemodinámica/efectos de los fármacos , Humanos , Cuidados Intraoperatorios/métodos , Persona de Mediana Edad , Isquemia Miocárdica/tratamiento farmacológico , Selección de Paciente , Cuidados Posoperatorios/métodos , Gestión de Riesgos , Rotura Espontánea
18.
Transplant Proc ; 35(5): 1834-5, 2003 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12962814

RESUMEN

Autonomic neuropathy (AN), which is frequently observed in cirrhosis patients, has been associated with a higher mortality. We have prospectively evaluated the prevalence of AN, its relationship with the degree of liver dysfunction and circulatory disturbances, and the evolution of AN after liver transplantation (LT) in 62 end-stage liver cirrhosis patients. AN was evaluated by seven cardiovascular tests assessing sympathetic or parasympathetic function before and 6 months after LT. Patients were classified as showing absent (A), early (E), or definite dysfunction (D). AN appeared in 67.7% of cases (E: 24.2%, D: 43.5%) without relation to liver disease etiology. Parasympathetic dysfunction was more prevalent than sympathetic dysfunction (59.7% vs. 20.9%). AN was significantly related to Child-Pugh score. Hyperdynamic circulation was more marked in the D than the A group as shown by a greater cardiac output (CO)(9 vs. 7.3 L/min) and a lower peripheral resistance (SVR)(666 vs. 866 dyn.s.cm(-5)). Moreover, AN scores significantly correlated with CO and SVR. Overall the prevalence of AN decreased 6 months after LT (67.7% vs 48%) due to a significant reduction in definite AN (43.5 vs. 14.8%; P<.05). AN improved in 70% of cases after LT. Sympathetic dysfunction remained in only one patient. We conclude that AN is frequent in liver transplant candidates; its severity is associated with the degree of liver failure. Systemic circulatory disturbances seem to correlate with the severity of AN. AN is clearly improved by LT. The evaluation of AN may contribute to a better selection of LT recipients.


Asunto(s)
Enfermedades del Sistema Nervioso Autónomo/fisiopatología , Cirrosis Hepática/fisiopatología , Cirrosis Hepática/cirugía , Trasplante de Hígado/fisiología , Enfermedades del Sistema Nervioso Autónomo/epidemiología , Circulación Sanguínea/fisiología , Humanos , Cirrosis Hepática/etiología , Cirrosis Hepática/patología , Complicaciones Posoperatorias/fisiopatología , Prevalencia
19.
Transplant Proc ; 35(5): 1866-8, 2003 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12962828

RESUMEN

INTRODUCTION: End-stage liver disease is frequently associated with autonomic neuropathy (AN). The hemodynamic changes during liver transplantation (LT) require an adequate autonomic response to maintain cardiovascular stability. PATIENTS AND METHODS: Forty-one patients undergoing LT were evaluated for the influence of AN on the evolution after LT. AN was previously evaluated by seven cardiovascular tests assessing sympathetic (Sy) or parasympathetic (P) function. Patients were classified as absent (A), early (E), or definite dysfunction (D). A hemodynamic study was performed before and after vascular clampings. The analysis included the duration of LT, transfusion requirements, intra-operative artenal hypotensive episodes, incidence of postreperfusion syndrome (PRS), cardiac arrhythmias and vasoactive drug requirements. RESULTS: The hyperdynamic circulation worsened during surgery in D patients, as shown by a significantly increased cardiac output and a significantly decreased systemic vascular resistance. The incidence of PRS was greater in the AN group. Arterial hypotension during the neohepatic period was more frequent among patients with AN, more frequently requiring vasoconstrictor and inotropic therapy. CONCLUSIONS: AN is associated with hemodynamic impairment and with increased vasoactive drug requirements during liver transplantation, probably associated with impaired reflex vasoconstrictor responses to surgical manipulations and changes of blood volume. AN may be associated with a greater surgical risk during LT. Preoperative evaluation of AN may select a high-risk population of LT recipients.


Asunto(s)
Enfermedades del Sistema Nervioso Autónomo/fisiopatología , Complicaciones Intraoperatorias/fisiopatología , Cirrosis Hepática/cirugía , Fallo Hepático/cirugía , Trasplante de Hígado/fisiología , Adulto , Anciano , Análisis de Varianza , Distribución de Chi-Cuadrado , Femenino , Hemodinámica , Hepatitis B/fisiopatología , Hepatitis B/cirugía , Hepatitis C/fisiopatología , Hepatitis C/cirugía , Humanos , Cirrosis Hepática/fisiopatología , Fallo Hepático/fisiopatología , Masculino , Persona de Mediana Edad
20.
Rev Esp Anestesiol Reanim ; 51(8): 438-46; quiz 446-7, 464, 2004 Oct.
Artículo en Español | MEDLINE | ID: mdl-15586537

RESUMEN

Managing postoperative pain from thoracotomy is one of the greatest challenges anesthesiologists face in daily practice. Proper management is assumed to improve the patient's prognosis. The thoracic paravertebral block, following its rediscovery, is being used with increasing frequency and success for both surgery and recovery from thoracotomy, challenging the supremacy of thoracic epidural analgesia, which to date has been considered the gold standard. We describe the history, anatomy, techniques and complications of the thoracic paravertebral block and review published randomized controlled trials comparing the thoracic paravertebral block to placebo and to epidural analgesia. In view of published evidence, it seems that the thoracic paravertebral block may replace the thoracic epidural technique as the gold standard for providing analgesia for patients undergoing thoracotomy.


Asunto(s)
Analgesia/métodos , Bloqueo Nervioso/métodos , Anestésicos/administración & dosificación , Humanos , Cuidados Intraoperatorios , Bloqueo Nervioso/efectos adversos , Cuidados Posoperatorios , Ensayos Clínicos Controlados Aleatorios como Asunto , Vértebras Torácicas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA